中芯(00981.HK)弹逾7%曾高见39.9元 A股网上发行获565倍超购
中芯国际(00981.HK)发行A股认购反应热烈,该股继昨天升至44.5元纪录高倒跌近9%後,今天曾急弹9.2%高见39.9元,现造39.2元,回升7.3%,成交1.916亿股,涉资73.59亿元。
中芯国际(688981.SH)公布网上发行申购及中签率情况,以每股27.46元人民币登陆上交所科创板,回拨机制启动前、超额配售选择权启用後,网上发行数量为4.21亿股,对比有效申购股份2,385.75亿股,相当於获566倍认购,启动网上、网下回拨机制启动後,网上发行最终中签率为0.21196071%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.